Cardiovascular Effects Mediated by HMMR and CD44

Area of Science:

• Cardiovascular research
• Inflammation biology
• Molecular cell biology

Background:

• Cardiovascular disease (CVD) is a major global health concern, with myocardial infarction and stroke as critical outcomes.
• Chronic inflammation, vascular damage, and oxidative stress are implicated in CVD pathogenesis.
• Hyaluronic acid (HA) signaling, mediated by receptors CD44 and RHAMM, is crucial in inflammatory processes.

Purpose of the Study:

• To elucidate the roles of hyaluronic acid receptors CD44 and RHAMM in the development of cardiovascular disease.
• To review the current understanding of CD44 and RHAMM functions in the context of CVD.
• To identify potential therapeutic strategies targeting these receptors for CVD treatment.

Main Methods:

• Literature review of studies investigating hyaluronic acid, CD44, RHAMM, and cardiovascular disease.
• Analysis of research on the molecular mechanisms linking inflammation and CVD.
• Synthesis of data on the cellular functions of CD44 and RHAMM in disease models.

Main Results:

• Both CD44 and RHAMM are implicated in cellular processes relevant to CVD, including inflammation and cell migration.
• While their structures differ, CD44 and RHAMM may exhibit synergistic or overlapping functions in disease.
• The precise contribution and interplay of these receptors in CVD pathogenesis require further investigation.

Conclusions:

• Hyaluronic acid receptors CD44 and RHAMM are significant players in the inflammatory pathways associated with cardiovascular disease.
• Understanding the specific roles of CD44 and RHAMM in CVD may reveal novel therapeutic targets.
• Further research is warranted to fully delineate the mechanisms and therapeutic potential of targeting CD44 and RHAMM in CVD.